These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 28329394

  • 1. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Krause M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, Müller D, Härtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ.
    Clin Infect Dis; 2017 Jun 15; 64(12):1637-1643. PubMed ID: 28329394
    [Abstract] [Full Text] [Related]

  • 2. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
    Derad I, Obermann B, Katalinic A, Eisemann N, Knobloch JK, Sayk F, Wellhöner P, Lehnert H, Solbach W, Süfke S, Steinhoff J, Nitschke M.
    Nephrol Dial Transplant; 2016 Jan 15; 31(1):95-103. PubMed ID: 26180049
    [Abstract] [Full Text] [Related]

  • 3. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
    Ağbaş A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S.
    Pediatr Nephrol; 2018 Dec 15; 33(12):2371-2381. PubMed ID: 30159625
    [Abstract] [Full Text] [Related]

  • 4. Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.
    Rosales A, Kuppelwieser S, Giner T, Hofer J, Riedl Khursigara M, Orth-Höller D, Borena W, Cortina G, Jungraithmayr T, Würzner R, German-Austrian H. U. S.-Study Group.
    Pediatr Nephrol; 2024 Aug 15; 39(8):2459-2465. PubMed ID: 38589699
    [Abstract] [Full Text] [Related]

  • 5. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 6. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.
    Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ.
    Clin Infect Dis; 2012 Sep 13; 55(6):753-9. PubMed ID: 22670043
    [Abstract] [Full Text] [Related]

  • 7. Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.
    Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C.
    Nephrol Dial Transplant; 2014 Mar 13; 29(3):565-72. PubMed ID: 24293658
    [Abstract] [Full Text] [Related]

  • 8. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W, Mihajlov V, Middendorf B, Mellmann A, Karch H, Lüth S, Ullrich S.
    J Gastroenterol Hepatol; 2018 Jul 13; 33(7):1353-1356. PubMed ID: 29280264
    [Abstract] [Full Text] [Related]

  • 9. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K, Tanne C, Kwon T, Faudeux C, Clave S, Langevin L, Pietrement C, Enoch C, Parmentier C, Mariani-Kurkdjian P, Weill FX, Jones G, Djouadi N, Morin D, Fila M.
    Arch Pediatr; 2022 Aug 13; 29(6):448-452. PubMed ID: 35662540
    [Abstract] [Full Text] [Related]

  • 10. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry.
    Nephrol Dial Transplant; 2012 Oct 13; 27(10):3807-15. PubMed ID: 23114903
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
    Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.
    Pediatr Nephrol; 2019 Apr 13; 34(4):657-662. PubMed ID: 30368614
    [Abstract] [Full Text] [Related]

  • 12. Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.
    Kemper MJ.
    Pediatr Nephrol; 2012 Feb 13; 27(2):161-4. PubMed ID: 22160440
    [Abstract] [Full Text] [Related]

  • 13. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
    Vonberg RP, Höhle M, Aepfelbacher M, Bange FC, Belmar Campos C, Claussen K, Christner M, Cramer JP, Haller H, Hornef M, Fickenscher H, Fraedrich K, Knobloch JK, Kühbacher T, Manns MP, Nitschke M, Peters G, Pulz M, Rohde H, Roseland RT, Sayk F, Schaumburg F, Schöcklmann HO, Schubert S, Solbach W, Karch H, Suerbaum S.
    Clin Infect Dis; 2013 Apr 13; 56(8):1132-40. PubMed ID: 23300241
    [Abstract] [Full Text] [Related]

  • 14. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D, King LA, Müller L, Follin P, Buchholz U, Bernard H, Rosner B, Ethelberg S, de Valk H, Höhle M.
    Am J Epidemiol; 2013 Sep 15; 178(6):984-92. PubMed ID: 23935124
    [Abstract] [Full Text] [Related]

  • 15. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team.
    N Engl J Med; 2011 Nov 10; 365(19):1771-80. PubMed ID: 21696328
    [Abstract] [Full Text] [Related]

  • 16. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK.
    JAMA; 2012 Mar 14; 307(10):1046-52. PubMed ID: 22416100
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of a household outbreak of Shiga-toxin-producing Escherichia coli in Poland due to secondary transmission of STEC O104:H4 from Germany.
    Januszkiewicz A, Szych J, Rastawicki W, Wołkowicz T, Chróst A, Leszczyńska B, Kuźma E, Roszkowska-Blaim M, Gierczyński R.
    J Med Microbiol; 2012 Apr 14; 61(Pt 4):552-558. PubMed ID: 22135021
    [Abstract] [Full Text] [Related]

  • 18. A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.
    Wu CJ, Hsueh PR, Ko WC.
    J Microbiol Immunol Infect; 2011 Oct 14; 44(5):390-3. PubMed ID: 21862425
    [Abstract] [Full Text] [Related]

  • 19. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.
    King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis E, Gault G, Jourdan-DaSilva N, Bingen E, Macé M, Thevenot D, Ong N, Castor C, Noël H, Van Cauteren D, Charron M, Vaillant V, Aldabe B, Goulet V, Delmas G, Couturier E, Le Strat Y, Combe C, Delmas Y, Terrier F, Vendrely B, Rolland P, de Valk H.
    Clin Infect Dis; 2012 Jun 14; 54(11):1588-94. PubMed ID: 22460976
    [Abstract] [Full Text] [Related]

  • 20. Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
    Percheron L, Gramada R, Tellier S, Salomon R, Harambat J, Llanas B, Fila M, Allain-Launay E, Lapeyraque AL, Leroy V, Adra AL, Bérard E, Bourdat-Michel G, Chehade H, Eckart P, Merieau E, Piètrement C, Sellier-Leclerc AL, Frémeaux-Bacchi V, Dimeglio C, Garnier A.
    Pediatr Nephrol; 2018 Aug 14; 33(8):1385-1394. PubMed ID: 29572749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.